Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2026)

Spero Therapeutics (SPRO) has reported Asset Utilization Ratio for 10 consecutive years, with 0.84 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio rose 21.02% year-over-year to 0.84; the trailing twelve-month figure through Jun 2026 stood at 0.84 (up 21.02% YoY), and the FY2025 full-year result was 0.74, up 127.28% from the prior year.
• Asset Utilization Ratio fell to 0.84 in Q2 2026 per SPRO's latest filing, from 0.96 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.09 in Q4 2025 and bottomed at 0.08 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.59 across 5 years, with a median of 0.66 in 2025.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 448.51% in 2023, then slumped 45.53% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.57 in 2022, then grew by 26.81% to 0.72 in 2023, then slumped by 45.53% to 0.39 in 2024, then surged by 177.94% to 1.09 in 2025, then declined by 22.53% to 0.84 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.84, 0.96, and 1.09 for Q2 2026, Q1 2026, and Q4 2025 respectively.